{"protocolSection":{"identificationModule":{"nctId":"NCT06125236","orgStudyIdInfo":{"id":"SWMU202309"},"organization":{"fullName":"The Affiliated Hospital Of Southwest Medical University","class":"OTHER"},"briefTitle":"Registration of Acute Ischemic Stroke With Large and Medium-sized Vascular Occlusion in Southwest China(LMVOS)","officialTitle":"Registration of Acute Ischemic Stroke With Large and Medium-sized Vascular Occlusion in Southwest China(LMVOS)","acronym":"LMVOS"},"statusModule":{"statusVerifiedDate":"2023-11","overallStatus":"RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2023-11-09","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2045-12-01","type":"ESTIMATED"},"completionDateStruct":{"date":"2046-05-01","type":"ESTIMATED"},"studyFirstSubmitDate":"2023-11-06","studyFirstSubmitQcDate":"2023-11-06","studyFirstPostDateStruct":{"date":"2023-11-09","type":"ACTUAL"},"lastUpdateSubmitDate":"2023-11-09","lastUpdatePostDateStruct":{"date":"2023-11-13","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR_INVESTIGATOR","investigatorFullName":"Zhengzhou Yuan","investigatorTitle":"Deputy Director of Stroke Center","investigatorAffiliation":"The Affiliated Hospital Of Southwest Medical University"},"leadSponsor":{"name":"Zhengzhou Yuan","class":"OTHER"}},"oversightModule":{"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"This study is designed to observe the treatment options in real-world clinical practice as well as the safety and efficacy of different treatment strategies.","detailedDescription":"LMVOS is a prospective, real-world registry lasting for 22 years. A total of 8000 patients with large- or medium-vessel occlusion will be enrolled."},"conditionsModule":{"conditions":["Acute Ischemic Stroke"]},"designModule":{"studyType":"OBSERVATIONAL","patientRegistry":false,"designInfo":{"observationalModel":"COHORT","timePerspective":"PROSPECTIVE"},"bioSpec":{"retention":"SAMPLES_WITH_DNA","description":"Blood and Thrombosis."},"enrollmentInfo":{"count":8000,"type":"ESTIMATED"}},"armsInterventionsModule":{"armGroups":[{"label":"Acute ischemic stroke with large- or medium-vessel occlusion","description":"Acute ischemic stroke patients with large- or medium-vessel occlusion including all treatments.","interventionNames":["Other: Visit at D90"]}],"interventions":[{"type":"OTHER","name":"Visit at D90","description":"Visits at 90±7 days after stroke onset were conducted by trained and blinded investigators, with face-to-face, telephone call or Internet access.","armGroupLabels":["Acute ischemic stroke with large- or medium-vessel occlusion"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"modified Rankin Scale (mRS) score","description":"Ordinal distribution of mRS at 90±7 days; modified Rankin scale (range, 0 to 6, with a score of 0 indicating no disability, 1 no clinically significant disability, 2 slight disability, 3 moderate disability but remaining able to walk unassisted, 4 moderately severe disability, 5 severe disability, and 6 death)","timeFrame":"90±7 days"}],"secondaryOutcomes":[{"measure":"Excellent functional outcome","description":"Proportion of subjects with mRS 0-1 at 90±7 days.","timeFrame":"90±7 days"},{"measure":"Good functional outcome","description":"Proportion of subjects with mRS 0-2 at 90±7 days.","timeFrame":"90±7 days"},{"measure":"mRS 0-3","description":"Proportion of subjects with mRS 0-3 at 90±7 days.","timeFrame":"90±7 days"},{"measure":"Change of National Institutes of Health Stroke Scale (NIHSS)","description":"Change of National Institutes of Health Stroke Scale (NIHSS, a scale between 0 and 42 on which higher scores indicate more severe neurologic deficits) from baseline to 24 hours.","timeFrame":"24 hours"},{"measure":"Change of National Institutes of Health Stroke Scale (NIHSS)","description":"Change of National Institutes of Health Stroke Scale (NIHSS, a scale between 0 and 42 on which higher scores indicate more severe neurologic deficits) from baseline to 7 days.","timeFrame":"7 days"},{"measure":"Symptom-to-thrombolysis time (STT)","description":"Time from onset of symptoms to thrombolytic therapy.","timeFrame":"24 hours"},{"measure":"Door-to-Needle Time","description":"Time from the arrival of stroke patient in emergency to initiation of thrombolysis therapy.","timeFrame":"24 hours"},{"measure":"Door-to-Puncture Time (DPT)","description":"ime from the arrival of stroke patient in emergency to groin puncture.","timeFrame":"24 hours"},{"measure":"Onset-to-recanalization time","description":"Time from symptom onset to the beginning of recanalization (recanalization defined as expanded TICI scale≥2b).","timeFrame":"24 hours"},{"measure":"Door-to-Recanalization Time (DRT)","description":"Time from the arrival of stroke patient in emergency to the beginning of recanalization (recanalization defined as expanded TICI scale≥2b).","timeFrame":"24 hours"},{"measure":"Puncture-to-recanalization time","description":"Time from groin puncture to recanalization (recanalization defined as expanded TICI scale≥2b).","timeFrame":"24 hours"}],"otherOutcomes":[{"measure":"Incidence of clinically significant intracranial hemorrhage","description":"Incidence of sICH (Heidelberg criteria) measured at 36 hours","timeFrame":"36 hours"},{"measure":"Incidence of any intracranial hemorrhage","description":"Incidence of any intracranial hemorrhage (Heidelberg criteria) measured at 36 hours","timeFrame":"36 hours"},{"measure":"All-cause mortality","description":"All-cause mortality at 90±7 days","timeFrame":"90±7 days"},{"measure":"Complications related to intravenous thrombolysis","description":"Complications related to intravenous thrombolysis during hospitalization","timeFrame":"up to 7 days"},{"measure":"Complications related to endovascular treatment","description":"Complications related to intravenous thrombolysis during hospitalization","timeFrame":"up to 7 days"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\nThe clinical diagnosis is acute ischemic stroke with large- or medium- vessel occlusion (the criteria followed the Chinese Guidelines for the Diagnosis and Treatment of Acute Ischemic Stroke 2018).\n\nInformed consent from the patient or surrogate.\n\nExclusion Criteria:\n\nNo additional exclusion criteria.","healthyVolunteers":false,"sex":"ALL","stdAges":["CHILD","ADULT","OLDER_ADULT"],"studyPopulation":"Patients with acute ischemic stroke due to large- or medium-vessel occlusion will be enrolled and no additional exclusion criteria are set.","samplingMethod":"NON_PROBABILITY_SAMPLE"},"contactsLocationsModule":{"centralContacts":[{"name":"Zhengzhou Yuan, MD","role":"CONTACT","phone":"+868303165661","email":"coneuro@163.com"}],"overallOfficials":[{"name":"Zhengzhou Yuan, MD","affiliation":"Department of Neurology, Affiliated Hospital of Southwest Medical University, LuZhou, China.","role":"STUDY_CHAIR"}],"locations":[{"facility":"Affiliated Hospital of Southwest Medical University","status":"RECRUITING","city":"Luzhou","zip":"646000","country":"China","contacts":[{"name":"Zhengzhou Yuan","role":"CONTACT","phone":"+868303165661"}]}]},"ipdSharingStatementModule":{"ipdSharing":"NO"}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"},{"id":"D000083242","term":"Ischemic Stroke"},{"id":"D000002544","term":"Cerebral Infarction"},{"id":"D000007511","term":"Ischemia"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"},{"id":"D000010335","term":"Pathologic Processes"},{"id":"D000020520","term":"Brain Infarction"},{"id":"D000002545","term":"Brain Ischemia"},{"id":"D000007238","term":"Infarction"},{"id":"D000009336","term":"Necrosis"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M10233","name":"Ischemia","asFound":"Ischemic","relevance":"HIGH"},{"id":"M2401","name":"Ischemic Stroke","asFound":"Ischemic Stroke","relevance":"HIGH"},{"id":"M9972","name":"Infarction","relevance":"LOW"},{"id":"M5483","name":"Cerebral Infarction","asFound":"Ischemic Stroke","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"M21995","name":"Brain Infarction","relevance":"LOW"},{"id":"M5484","name":"Brain Ischemia","relevance":"LOW"},{"id":"M11974","name":"Necrosis","relevance":"LOW"},{"id":"T170","name":"Acute Graft Versus Host Disease","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"Rare","name":"Rare Diseases"}]}},"hasResults":false}